AI Boom and Overbought Stocks: Major beneficiaries of the AI boom, like Micron and Advanced Micro Devices, are now considered overbought according to the 14-day relative strength index (RSI), with Caterpillar leading the list at an RSI of 79.1.
Market Performance: Despite volatility, all three major U.S. indexes posted weekly gains, with the S&P 500 up 1.7%, the Dow up 1.6%, and the Nasdaq Composite up 2.1%, as third-quarter earnings appear positive.
Caterpillar's Role in AI: Caterpillar is highlighted as a key player in the AI data center buildout, with significant stock gains this year, while analysts suggest further potential for semiconductor stocks like AMD, which has seen a 93% increase in value.
Bunge Global's Surge: Bunge Global is also identified as overbought with an RSI of 76.7, experiencing a 20% jump this week due to geopolitical tensions affecting U.S.-China trade relations, particularly in the soybean market.
Wall Street analysts forecast BG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BG is 115.50 USD with a low forecast of 109.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast BG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BG is 115.50 USD with a low forecast of 109.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 112.070
Low
109.00
Averages
115.50
High
120.00
Current: 112.070
Low
109.00
Averages
115.50
High
120.00
JPMorgan
Thomas Palmer
Overweight
maintain
$109 -> $117
2026-01-21
New
Reason
JPMorgan
Thomas Palmer
Price Target
$109 -> $117
AI Analysis
2026-01-21
New
maintain
Overweight
Reason
JPMorgan analyst Thomas Palmer raised the firm's price target on Bunge to $117 from $109 and keeps an Overweight rating on the shares. The firm updated targets in the agricultural products group ahead of the Q4 reports. The ag products industry "seems to be experiencing an improved environment," the analyst tells investors in a research note. JPMorgan says soybean board crush futures are pointing to better margins as 2026 progresses.
BofA
NULL -> Buy
upgrade
$112 -> $119
2026-01-08
Reason
BofA
Price Target
$112 -> $119
2026-01-08
upgrade
NULL -> Buy
Reason
BofA raised the firm's price target on Bunge to $119 from $112 and keeps a Buy rating on the shares. The firm is updating its price targets for Chemicals under its coverage, the analyst tells investors. Commodities face another year of growing oversupply, specialties continue to manage an inconsistent backdrop, and agriculture presents a more mixed setup, the firm adds. BofA highlights that there are areas for optimism, with several possible catalysts for the stocks including PMI indicators shifting positive, rate cuts, and potential capacity rationalization in China. The firm cautions, however, that these catalysts are too new to rely on.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BG
Unlock Now
Morgan Stanley
Equal Weight -> Overweight
upgrade
$95 -> $120
2025-12-16
Reason
Morgan Stanley
Price Target
$95 -> $120
2025-12-16
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Bunge to Overweight from Equal Weight with a price target of $120, up from $95. The firm says synergy optionality creates a favorable risk/reward in shares of Bunge. The Viterra synergies will likely surprise positively, the analyst tells investors in a research note.
BofA
Buy
maintain
$95 -> $112
2025-12-02
Reason
BofA
Price Target
$95 -> $112
2025-12-02
maintain
Buy
Reason
BofA raised the firm's price target on Bunge to $112 from $95 and keeps a Buy rating on the shares, citing updated earnings forecasts and confidence in synergy realization from the Viterra deal. The firm, which assumes that most of the synergy capture will be materialized by yearend 2027 and market dynamics will improve, raised its 2026-27 EPS forecasts to $8.35 and $10.70, respectively.
About BG
Bunge Global SA is an agribusiness solutions company. The Company is engaged in the processing of oil seeds and the production and supply of specialty vegetable oils and fats. Its segments include Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The Soybean Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybean and soybean related products, as well as biodiesel and fertilizer production and distribution. The Softseed Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, refining, marketing, and sale of soft seeds (canola/rapeseed, sunflower seed, and safflower seed) and soft seed related products, as well as biodiesel production and distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
